Int. J. Mol. Sci. 2008, 9(9), 1561-1594; doi:10.3390/ijms9091561
Review

Broad-Spectrum Drugs Against Viral Agents

Defence Research & Development Canada – Suffield, Box 4000, Station Main, Medicine Hat, AB, Canada
* Author to whom correspondence should be addressed.
Received: 18 April 2008; Accepted: 29 August 2008 / Published: 1 September 2008
(This article belongs to the Special Issue Nucleic Acid Derivatives in Emerging Technologies)
PDF Full-text Download PDF Full-Text [234 KB, uploaded 2 October 2008 12:05 CEST]
Abstract: Development of antivirals has focused primarily on vaccines and on treatments for specific viral agents. Although effective, these approaches may be limited in situations where the etiologic agent is unknown or when the target virus has undergone mutation, recombination or reassortment. Augmentation of the innate immune response may be an effective alternative for disease amelioration. Nonspecific, broad-spectrum immune responses can be induced by double-stranded (ds)RNAs such as poly (ICLC), or oligonucleotides (ODNs) containing unmethylated deocycytidyl-deoxyguanosinyl (CpG) motifs. These may offer protection against various bacterial and viral pathogens regardless of their genetic makeup, zoonotic origin or drug resistance.
Keywords: CpG; cytokine; influenza; poly (ICLC); TLR

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Christopher, M.E.; Wong, J.P. Broad-Spectrum Drugs Against Viral Agents. Int. J. Mol. Sci. 2008, 9, 1561-1594.

AMA Style

Christopher ME, Wong JP. Broad-Spectrum Drugs Against Viral Agents. International Journal of Molecular Sciences. 2008; 9(9):1561-1594.

Chicago/Turabian Style

Christopher, Mary E.; Wong, Jonathan P. 2008. "Broad-Spectrum Drugs Against Viral Agents." Int. J. Mol. Sci. 9, no. 9: 1561-1594.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert